Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Service d'aide à la décision clinique
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0


Revue Neurologique
Volume 165, n° 10
pages 739-741 (octobre 2009)
Doi : 10.1016/j.neurol.2009.07.012
What has positron emission tomography told us about the epileptogenic zone?
Que nous a apporté la tomographie d’émission de positons pour la localisation de la zone épileptogène ?
 

A. Hammers
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College London, South Kensington, Hammersmith Hospital, London SW7 2DD, United Kingdom 

Abstract

There is no one ligand for visualising “the epileptogenic zone”. Several PET ligands, however, can help by noninvasively or minimally invasively refining hypotheses regarding its location. Their relative merits depend not only on local availability and expertise, but also on epilepsy syndrome and overall diagnostic category. FDG, flumazenil (FMZ), alpha-methyl-tryptophan (AMT), the 5-HT1A ligands, and diprenorphine are discussed.

The full text of this article is available in PDF format.
Résumé

Il n’existe pas de ligand unique permettant de visualiser « la zone épileptogène ». En revanche, plusieurs ligands peuvent être utiles pour affiner de façon peu ou non-invasive des hypothèses quant à sa localisation. Leurs avantages respectifs dépendent non seulement de leur disponibilité et des expertises locales, mais aussi du syndrome en question et de la catégorie diagnostique globale de l’épilepsie. Le FDG, le flumazénil, l’alpha-méthyl-tryptophane, les ligands 5-HT1A et la diprénorphine sont discutés.

The full text of this article is available in PDF format.

Keywords : Epileptogenic zone, PET, FDG, Flumazenil, Alpha-methyl-tryptophan, Diprenorphine

Mots clés : Zone épileptogène, TEP, FDG, Flumazénil, Alpha-méthyl-tryptophane, Diprénorphine




© 2009  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline